WHO Advises Against Use of Remdesivir on COVID Patients
Clinical trials show there currently is no evidence the antiviral drug improves survival of patients, no matter how severely ill they are
Full Article
WHO Advises Against Use of Remdesivir on COVID Patients
VOA News
0 shares
1 views
You might like
Related news coverage
Humanigen showing positive results for cancer drug lenzilumab, also used to treat patients hospitalized with coronavirus
Proactive Investors
Key drug candidate lenzilumab is a recombinant monoclonal antibody Designed to reduce sometimes dangerous side effects associated..
-
'Not of use for much': Hospitals told not to give remdesivir to COVID-19 patients
Upworthy
-
Post Holdings, Gilead Sciences fall; Pfizer, Hibbett rise
SeattlePI.com
-
Don't use Gilead's Remdesivir in hospitalised COVID-19 patients: WHO
Zee News
-
WHO advises against use of remdesivir for hospitalised COVID-19 patients
newKerala.com
Advertisement
More coverage
A year on, COVID-19 is still an unsolved mystery
Mid-Day
The first case of novel Coronavirus -- SARS-CoV2 -- was reported on November 17, 2019, in China's Wuhan city, and in March, the WHO..
-
Don’t use remdesivir in hospitalised Covid-19 patients: WHO
Indian Express
-
WHO warns against remdesivir for COVID-19 treatment
Mid-Day
-
WHO Recommends Against Using Gilead Sciences' Remdesivir For Covid
RTTNews
-
FDA Issues Emergency Approval To Lilly's Arthritis Drug With Remdesivir For COVID-19 Treatment
RTTNews